TAK1 inhibition accelerates cellular senescence of retinal pigment epithelial cells

Zeev Dvashi1, Yaron Green1, Ayala Pollack1

  • 1Kaplan Medical Center, affiliated with Hadassah-Hebrew University of Jerusalem, Rehovot, Israel.

Abstract

Insights

Transforming growth factor-β-activated kinase 1 (TAK1) inhibition promotes RPE cell senescence, a key factor in dry age-related macular degeneration (AMD). This suggests TAK1 plays a crucial role in RPE cell function and offers potential therapeutic targets for AMD.

Area of Science:

  • Ophthalmology
  • Cell Biology
  • Molecular Biology

Background:

  • Oxidative stress and cellular senescence are implicated in Age-related Macular Degeneration (AMD) pathogenesis.
  • The precise mechanisms linking these factors to AMD, particularly dry AMD, remain incompletely understood.
  • Retinal Pigment Epithelial (RPE) cells are critical for retinal health and are susceptible to senescence.

Purpose of the Study:

  • To investigate the role of Transforming Growth Factor-β-Activated Kinase 1 (TAK1) in the senescence of RPE cells.
  • To model the contribution of RPE cell senescence to the development of dry AMD.
  • To explore TAK1's mechanism in oxidative stress-induced RPE cell senescence.

Main Methods:

  • Human RPE cells were treated with a TAK1 inhibitor (5Z-7-oxozeaenol) followed by hydrogen peroxide exposure.
  • Senescence was assessed by detecting senescence-associated β-galactosidase (SA-β-gal) activity.
  • Cell-cycle progression and apoptosis rates were analyzed using flow cytometry, and p53 expression was evaluated via immunoblotting.

Main Results:

  • TAK1 expression was found to be high in RPE cells and altered by oxidative stress.
  • TAK1 inhibition reduced cell proliferation, induced G0/G1 cell-cycle arrest, and increased SA-β-gal expression, indicating senescence.
  • Combined TAK1 inhibition and oxidative stress decreased apoptotic protein expression (e.g., p53) and promoted RPE cell senescence, with aberrant TAK1 activity inducing fibrotic changes in neighboring cells.

Conclusions:

  • In vitro findings suggest TAK1 is involved in initiating RPE cell senescence.
  • TAK1 activity is essential for maintaining the normal function of RPE cells.
  • Understanding TAK1's role in RPE senescence could lead to novel therapeutic strategies for halting dry AMD progression.